Deep knowledge on
small-molecule drugs and
the 90,000 global patents
|Title:||Dosage and inserter for treatment of erectile dysfunction|
|Abstract:||Erectile dysfunction, particularly impotence, priapism and Peyronie's disease is treated by the transurethral administration of a therapeutically effective agent. The agents are administered to the urethra by means of a penile insert (40) having a shaft with a deformable distal end which forms a dose receiving cavity when an internal piston is retracted relative to the shaft.|
|Inventor(s):||Place; Virgil A. (Kawaihae, HI), Gale; Robert M. (Los Altos, CA), Berggren; Randall G. (Livermore, CA)|
|Assignee:||Vivus, Inc. (Menlo Park, CA)|
Patent Claim Types:|
see list of patent claims
|Use; Dosage form; Composition;|
|Country||Document Number||Publication Date||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Portugal||97441||Aug 31, 1998|
|South Africa||9102984||Jan 29, 1992|
|Ireland||81089||Mar 08, 2000|
|Canada||2352552||Oct 26, 1991|
|Norway||924032||Oct 26, 1992|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.